Decoding Emotional Dynamics Driving Mood Instability in Bipolar Disorder
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 72
- 试验地点
- 1
- 主要终点
- Decoded Emotional State Trajectory
研究概览
简要总结
The goal of this neuroimaging study is to investigate how emotional states fluctuate in people with bipolar disorder (BD) compared to healthy controls, and to understand the neural mechanisms driving mood instability. The main questions it aims to answer are:
- Can emotional states be decoded from fMRI brain activity using machine learning?
- Do individuals with BD show more unstable emotional state trajectories (e.g., high metastability, low fractal scaling) than healthy controls?
- Does amplifying positive emotions stabilize brain and emotional dynamics in BD?
Researchers will compare individuals with bipolar disorder (BD-I or BD-II, currently depressed or mixed state) to healthy controls without psychiatric history to see whether the BD group shows greater fluctuations in emotional brain activity and whether positive emotion regulation strategies normalize this instability.
Participants will:
- Complete self-report questionnaires on mood, emotion regulation, anxiety, and daily functioning.
- Recall and provide short descriptions of personal positive and negative memories to be used in the MRI task.
- Undergo fMRI scanning, including:
- Resting-state scans
- A Think and Regulate Affective States Task (TReAT) where they recall autobiographical memories, rate emotions, and practice amplifying positive mood.
- Structural and diffusion MRI for brain mapping.
- Receive physiological monitoring (heart rate, respiration) during scanning.
- Complete post-scan surveys on emotional state and task experience.
This research will help clarify how the brain supports or disrupts emotional regulation in bipolar disorder and may inform the development of personalized, neurobiologically informed treatments for mood instability.
详细描述
This neuroimaging study investigates the neural mechanisms underlying emotional dynamics and mood instability in individuals with bipolar disorder (BD). Bipolar disorder is characterized by rapid and intense mood fluctuations, yet the neurobiological basis of these transitions, how the brain shifts between emotional states in real time, remains poorly understood. The study aims to identify the moment-to-moment brain processes that drive emotional lability and to explore whether positive emotion amplification can stabilize emotional and neural states in BD.
Study Design
This is a study conducted at the Laureate Institute for Brain Research (LIBR) in Tulsa, Oklahoma. The study includes 72 participants total: 36 adults diagnosed with bipolar disorder type I or II (currently in a depressive or mixed state) and 36 healthy control participants without psychiatric history. Participants will complete two visits:
- A preparation session for consent, clinical interviews, and questionnaire completion, and
- A MRI scanning session that includes both resting-state and task-based fMRI.
Data will be collected using multimodal methods, including functional magnetic resonance imaging (fMRI), diffusion weighted imaging (DWI), structural MRI, and physiological monitoring (heart rate, respiration). Behavioral and emotional measures will be recorded throughout the study to align neural data with subjective emotional experience.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age 18 to 65 years
- •Male or female
- •BMI between 18.5 and 38.0 kg/m2 at Screening
- •Capable of understanding and complying with study requirements
- •Fluent in English
- •Able to provide informed consent
- •Meet the DSM-5 diagnostic criteria for BD-I or BD-II who are currently depressed or mixed state defined by the Mini-International Neuropsychiatric Interview (MINI)
- •Moderate or greater depressive symptom severity (MADRS ≥ 15 or PHQ-9 ≥ 10)
- •No current or past psychiatric disorder (verified by MINI)
排除标准
- •No telephone or easy access to a telephone
- •Significant medical problems as identified by the medical screening questionnaire: e.g. a history of unstable liver or renal insufficiency; glaucoma; significant and unstable cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic, or metabolic disturbance; or any other condition that, in the opinion of the investigator, would make participation not be in the best interest (e.g., compromise the well-being) of the participant or that could prevent, limit, or confound the protocol-specified assessments
- •A positive test for drugs of abuse, including alcohol (breath test), cocaine, opiates, amphetamines, methamphetamines, phencyclidine, benzodiazepines, barbiturates, methadone, and oxycodone
- •Drug or alcohol intoxication (based on positive UTOX or breathalyzer test at screening or study session) or reported alcohol/drug withdrawal, last cannabis use must be >48 hours prior to study session.
- •Current DSM-5 diagnosis of a psychosis spectrum disorder or moderate to severe substance use disorder
- •Moderate to severe traumatic brain injury or other neurocognitive disorder with evidence of neurological deficits, neurological disorders, or severe or unstable medical conditions that might be compromised by participation in the study (to be determined by primary care provider)
- •Current significant suicidal ideation or suicide attempt within the past 3 months.
- •Change in the dose or prescription of a medication within the 6 weeks before enrolling in the study that could affect brain functioning, e.g., anxiolytics, antipsychotics, antidepressants, or mood stabilizers
- •Taking drugs that affect the fMRI hemodynamic response (e.g., methylphenidate, acetazolamide, excessive caffeine intake > 1000 mg/day)
- •MRI contraindications as documented on the MR Environment Screening
- •Unwillingness or inability to complete any of the major aspects of the study protocol, including magnetic resonance imaging (i.e., due to claustrophobia), or behavioral assessment. However, failing to complete some individual aspects of these assessment sessions will be acceptable (i.e., being unwilling to answer individual items on some questionnaires or being unwilling to complete a behavioral task)
- •Non-correctable vision or hearing problems
研究组 & 干预措施
Decoding Emotional Dynamics
All participants complete the same two-session protocol: a preparation visit with diagnostic interviews and questionnaires, followed by an MRI session including resting-state and task-based scans. During the Think and Regulate Affective States Task (TReAT), participants recall personal positive and negative memories, rate their emotions, and practice positive emotion amplification strategies. Physiological signals are recorded throughout. Both individuals with bipolar disorder and healthy controls complete identical procedures for comparison of brain and emotional dynamics.
干预措施: Think and Regulate Affective State Task (Behavioral)
结局指标
主要结局
Decoded Emotional State Trajectory
时间窗: Day 2
The decoded emotional state time course derived from fMRI during the Think and Regulate Affective States Task (TReAT). Temporal irregularity will be quantified using permutation entropy to assess emotional state instability in individuals with bipolar disorder compared to healthy controls.
Metastability of brain network states
时间窗: Day 2
Metastability of brain network states will be calculated from whole-brain fMRI data to characterize variability in emotional states.
次要结局
- Brain regional contributions to the transition energy of emotional brain state changes(Day 2)
- Fractal scaling of brain state changes(Day 2)
研究者
Masaya Misaki
Associate Investigator
Laureate Institute for Brain Research, Inc.